BiVictriX Therapeutics (BVX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

11.25p
   
  • Change Today:
    -0.50p
  • 52 Week High: 15.90
  • 52 Week Low: 10.50
  • Currency: UK Pounds
  • Shares Issued: 82.53m
  • Volume: 14,569
  • Market Cap: £9.28m

BVX Overview

BVX has identified a unique, cancer-restricted antigen fingerprint, absent from healthy cells, which can be exploited to produce cancer selective therapeutics. The Bi-Cygni® technology has been developed to exploit this concept and expedite the development of bispecific therapeutics with an improved therapeutic index. Based on BVX's work to date, these ADCs demonstrate superior potency and tumour selectivity compared to conventional ADCs. The main country of operation is in the UK.

Key Personnel

CEO: Tiffany Jane Thorn
Independent Non-Executive Director: Robert Edward Hawkins
Independent Non-Executive Director: Susan Day Lowther
Non-Executive Chairman: Michael Kauffman
Senior Independent Non-Executive Director: William Drummond Paris
Non-Executive Dir:

Contact Details

Address: Mereside, Alderley Park ,Alderley Edge, Macclesfield, United Kingdom, SK10 4TG
Website: http://www.bivictrix.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BNXH3K91

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

BVX Market Data

Currency UK Pounds
Share Price 11.25p
Change Today -0.50p
% Change -4.26 %
52 Week High 15.90
52 Week Low 10.50
Volume 14,569
Shares Issued 82.53m
Market Cap £9.28m

BVX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
50.53% below the market average50.53% below the market average50.53% below the market average50.53% below the market average50.53% below the market average
48.15% below the sector average48.15% below the sector average48.15% below the sector average48.15% below the sector average48.15% below the sector average
Price Trend
58.86% below the market average58.86% below the market average58.86% below the market average58.86% below the market average58.86% below the market average
19.30% above the sector average19.30% above the sector average19.30% above the sector average19.30% above the sector average19.30% above the sector average
Income Not Available
Growth Not Available

BVX Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
15:40 5 @ 10.50p
15:25 5 @ 10.50p
13:57 4,559 @ 11.55p

BVX Key Personnel

CEO Tiffany Jane Thorn

Top of Page